Showing results (141-150 of 170) with videos related to
Sort By:
Pageof 17
Bone Marrow Transplantation|February 20, 2013
Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantationR Romee, D J Weisdorf, C Brunstein, et al.Diabetologia|February 19, 2011
A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humansC J Huang, A E Butler, A Moran, et al.Bone Marrow Transplantation|January 14, 2009
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched unitsC G Brunstein, J N Barker, D J Weisdorf, et al.Progress in Clinical and Biological Research|January 1, 1990
Using elutriation to engineer bone marrow allograftsS J Noga, J E Wagner, S D Rowley, et al.Blood|July 15, 1995
Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu miceJ E Wagner, D Collins, S Fuller, et al.The American Journal of Medicine|November 1, 1988
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine casesR B Mitchell, J E Wagner, J E Karp, et al.Blood|February 27, 2001
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantationK Weinberg, B R Blazar, J E Wagner, et al.British Journal of Haematology|March 1, 1997
Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasiaS M Davies, J E Wagner, T Defor, et al.Blood|October 1, 1988
Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trialJ E Wagner, A D Donnenberg, S J Noga, et al.Blood|March 15, 1990
Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trialJ E Wagner, G W Santos, S J Noga, et al.Pageof 17